Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2015

Commitments and Contingencies [Abstract]

CytRx’s current contractual obligations that will require future cash payments are as follows (in thousands):

	Operating Leases (1)		Employment Agreements (2)		Research and Development (3)		Total
2016	$	318	$	3,647	$	27,940	$	31,905
2017		383		1,057		8,652		10,092
2018		363		1,057		86		1,506
2019		278		—		11		289
2020		59		—		—		59
Thereafter		—		—		—		—
Total	$	1,401	$	5,761	$	36,689	$	43,851

____________

(1)	Operating leases are primarily facility lease related obligations, as well as equipment lease obligations with third party vendors. The Company recognized rent expenses of $351,075, $335,991, and $315,134 in 2015, 2014 and 2013, respectively.

(2)

Employment agreements include management contracts which have been revised from time to time. The employment agreement for the Company's executive officers provide for minimum salaries, which are adjusted annually at the discretion of the Company's Compensation Committee, and in some cases provide for minimum annual bonuses, and employee benefits, as well. New employment agreements for the Company's other executive officers are usually entered into annually or biennially.

(3)	Research and development obligations relate primarily to clinical trials. All of these purchase obligations are cancelable..